Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 26.66
-0.38 (-1.41%)
Jun 2, 2026, 3:04 PM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 3.07 billion as of June 2, 2026. Its market cap has increased by 61.11% in one year.
Market Cap
3.07B
Enterprise Value
4.39B
Revenue
628.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.66
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 3.07B, a decrease of -53.30%. That is a compound annual growth rate of -13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.07B | 35.40% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baolingbao Biology | 3.50B |
| Qingdao Vland Biotech INC. | 3.27B |
| Shanghai Shen Lian Biomedical | 3.23B |
| Guanhao Biotech | 3.18B |
| Landfar Bio-medicine | 3.15B |
| Zhejiang Shouxiangu Pharmaceutical | 3.09B |
| Guangdong VTR Bio-Tech | 3.08B |
| Novoprotein Scientific | 2.93B |